 Servier submits that, for the purposes of s 102(2)(b) , when considering whether or not the proposed new claims are fairly based, the Court is required notionally to add the proposed amendments and then to consider the whole of the proposed amended specification to determine if it complies with s 40(3).
 Apotex contends that the skilled addressee would understand that it is the homogeneous distribution of crystals of about 0.2mm in size, and not their shape, that gives good filtration characteristics.
 Servier also disputes Apotex's contention that, unless the individual needle claims are limited by size and homogeneity or by the requirement that the individual needles be readily filterable, they are not "in substance disclosed" or fairly based.
